Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts-Reference-Cited by-同舟云学术

Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts

Published:2002-12-11 Issue:4 Volume:103 Page:501-507
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ara Gulshan,Baher Angelo,Storm Neal,Horan Tom,Baikalov Claudia,Brisan Emil,Camacho Reuben,Moore Alison,Goldman Hartt,Kohno Tadahiko,Cattley Russell C.,Van Gwyneth,Gaida Kevin,Zhang Ming,Whoriskey John S.,Fong David,Yoshinaga Steven K.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. T-cell co-stimulation through B7RP-1 and ICOS

2. Stimulatory Effects of B7-Related Protein-1 on Cellular and Humoral Immune Responses in Mice

3. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS

4. The Concept of Immunological Surveillance

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology Advances in Disease Treatment;International Encyclopedia of Public Health;2025

2. Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade;Cancer Research Communications;2023-08-16

3. Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design;Future Oncology;2021-06

4. Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand;Journal of Leukocyte Biology;2021-02-02

5. ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models;PLOS ONE;2020-09-24